...
首页> 外文期刊>Infectious disorders drug targets >Hepatitis A Seroprevalence Among Patients with Chronic Hepatitis B Infection: A Cross-Sectional Study in Iran During 2016-2017 Bentham Science
【24h】

Hepatitis A Seroprevalence Among Patients with Chronic Hepatitis B Infection: A Cross-Sectional Study in Iran During 2016-2017 Bentham Science

机译:Hepatitis A Seroprevalence Among Patients with Chronic Hepatitis B Infection: A Cross-Sectional Study in Iran During 2016-2017 Bentham Science

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: The aim of this study was to determine the prevalence of exposure tohepatitis A by means of serologic markers in chronic hepatitis B patients, with the secondary aimof finding the best prevention method for hepatitis A infection in susceptible groups of our setting.Methods: During the period between 2016 and 2017, we recruited 403 hepatitis B patients agedmore than 14 years and regularly attending the infectious diseases clinic at a referral universityhospital, Tehran, Iran. A blood sample was collected from all the patients and tested for hepatitisA IgG. The data was analyzed by SPSS v.19.Results: Although none of the patients had previously received hepatitis A vaccine, the results forserologic level of hepatitis A IgG, demonstrated positive results in 379 (94%) cases. The meanage of patients with negative and positive IgG was 29.17 and 42.46 years, respectively; the differencewas statistically significant (P≤0.001). The majority of seronegative patients were youngadults aged < 25 years and 25 to 35 years (P <0.001).Conclusion: Seroprevalence of hepatitis A in chronic HBV patients in Iran is high. As HBV infectedpatients younger than 35 years could be seronagative for HAV infection, evaluation ofthese patients for HAV infection and vaccination of seronegative patients would be a reasonableapproach.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号